| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.031 | 0.5 |